These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 6393864)
1. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys. Schmidt LH; Rossan RN Antimicrob Agents Chemother; 1984 Nov; 26(5):611-42. PubMed ID: 6393864 [TBL] [Abstract][Full Text] [Related]
2. Quantitative aspects of pyrimethamine-sulfonamide synergism. Schmidt LH; Harrison J; Rossan RN; Vaughan D; Crosby R Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):837-49. PubMed ID: 410317 [TBL] [Abstract][Full Text] [Related]
3. Long-acting, repository antimalarial agents. Duration of protection in mice and monkeys following administration of pyrimethamine pamoate. Werbel LM; Jacobs RL; Steinkampf RW; Worth DF Am J Trop Med Hyg; 1984 Jul; 33(4):526-33. PubMed ID: 6236702 [TBL] [Abstract][Full Text] [Related]
4. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates. Edstein MD; Yeo AE; Shanks GD; Rieckmann KH Acta Trop; 1997 Sep; 66(3):127-35. PubMed ID: 9210963 [TBL] [Abstract][Full Text] [Related]
5. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro. Watkins WM; Sixsmith DG; Chulay JD Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Peterson DS; Milhous WK; Wellems TE Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222 [TBL] [Abstract][Full Text] [Related]
7. Studies on the 2,4-diamino-6-substituted quinazolines. III. The capacity of sulfadiazine to enhance the activities of WR-158,122 and WR-159,412 against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmodium vivax in owl monkeys. Schmidt LH Am J Trop Med Hyg; 1979 Sep; 28(5):808-18. PubMed ID: 114066 [TBL] [Abstract][Full Text] [Related]
8. Activities of the tetrahydrofuran derivative, BA-41,799, against Plasmodium cynomolgi infections in rhesus monkeys. Schmidt LH Antimicrob Agents Chemother; 1985 Feb; 27(2):146-50. PubMed ID: 3985599 [TBL] [Abstract][Full Text] [Related]
9. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates. Schapira A Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024 [TBL] [Abstract][Full Text] [Related]
10. A rabbit--in vitro system to evaluate drug action against Plasmodium falciparum. Mrema JE; Rieckmann KH Trans R Soc Trop Med Hyg; 1983; 77(1):130-5. PubMed ID: 6222522 [TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Basco LK; Ringwald P Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Basco LK; Ramiliarisoa O; Le Bras J Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812 [TBL] [Abstract][Full Text] [Related]
14. Studies on the 2,4-diamino-6-substituted quinazolines. II. Activities of selected derivatives against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmodium vivax in owl monkeys. Schmidt LH Am J Trop Med Hyg; 1979 Sep; 28(5):793-807. PubMed ID: 114065 [TBL] [Abstract][Full Text] [Related]
15. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum]. Pinheiro L; Rosário VE Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208 [TBL] [Abstract][Full Text] [Related]
16. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains]. Basco LK; Le Bras J Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil. Petersen E; Hogh B; Hanson AP; Bjorkman A; Flacks H Ann Trop Med Parasitol; 1990 Dec; 84(6):563-71. PubMed ID: 2076034 [TBL] [Abstract][Full Text] [Related]
18. Genome comparison of progressively drug resistant Plasmodium falciparum lines derived from drug sensitive clone. Toteja R; Nair L; Bhasin V Mem Inst Oswaldo Cruz; 2001 Apr; 96(3):427-33. PubMed ID: 11313656 [TBL] [Abstract][Full Text] [Related]
19. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax]. Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948 [TBL] [Abstract][Full Text] [Related]
20. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand. Edstein MD; Bahr S; Kotecka B; Shanks GD; Rieckmann KH Antimicrob Agents Chemother; 1997 Oct; 41(10):2300-1. PubMed ID: 9333069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]